SCHEMBL4292194

SCHEMBL4292194

CCOc1ccc(C(O)c2c(O)cc(COC(C)=O)cc2F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.40
ALDH1A1 P00352 1/20 0.40
THRA P10827 1/20 0.38
THRB P10828 1/20 0.38
SLC5A1 P13866 1/20 0.38
SLC5A2 P31639 1/20 0.38
LMNA P02545 3/20 0.38
POLB P06746 3/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
ACACB O00763 2/20 0.37
ACACA Q13085 1/20 0.37
FFAR1 O14842 2/20 0.37
MAOA P21397 1/20 0.37
PPARG P37231 1/20 0.37
PPARD Q03181 1/20 0.37
PPARA Q07869 1/20 0.37
MAPT P10636 2/20 0.37
MAPK1 P28482 2/20 0.37
TDP1 Q9NUW8 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4281303 0.91 SLC5A1 (0.40) MAOBSLC5A1SLC5A2LMNAACACB
SCHEMBL4285592 0.89 POLB (0.39) MAOBALDH1A1SLC5A1SLC5A2LMNA
SCHEMBL4292204 0.88 ALDH1A1 (0.40) ALDH1A1SLC5A1SLC5A2LMNAPOLB
SCHEMBL4285479 0.87 ALDH1A1 (0.36) MAOBALDH1A1LMNAPOLBMEN1
SCHEMBL4279556 0.87 POLB (0.39) MAOBALDH1A1POLBACACBACACA
SCHEMBL4292575 0.86 ALDH1A1 (0.37) MAOBALDH1A1THRATHRBSLC5A1
SCHEMBL27767699 0.86 NPBWR1 (0.38) MAOBALDH1A1LMNAMAPTL3MBTL1
SCHEMBL27767693 0.84 PLG (0.37) ALDH1A1
SCHEMBL4279710 0.78 MAOB (0.48) MAOBALDH1A1THRBSLC5A1SLC5A2
SCHEMBL4279412 0.78 MAPT (0.43) MAOBALDH1A1SLC5A1SLC5A2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 MAOB 3258/4885ALDH1A1 896/4885THRA 3664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.